Work

Multiple Complete Responses in a Phase 1 Dose-Escalation Study of the Antibody-Drug Conjugate SGN-35 in Patients with Relapsed or Refractory CD30-Positive Lymphomas.

Year: 2008

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v112.11.1006.1006

Authors: Anas Younes, Andres Forero-Torres, Nancy L. Bartlett, John P. Leonard, Carmel Lynch, Dana A. Kennedy, Eric Sievers

Institutions: The University of Texas MD Anderson Cancer Center, University of Alabama at Birmingham, Washington University in St. Louis, Weill Cornell Medicine, Seagen (United States)

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2576112374

FWCI: 9.056

Cites:

Cited by: 59

Related to: 10